After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Recently, Yahoo Finance discussed the stock, revealing that Summit Therapeutics Announces Updated Phase II Data for Ivonescimab at 42nd Annual J.P. Morgan Healthcare Conference.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Summit Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $3.46 and fluctuated between $3.4800 as its day high and $2.9600 as its day low. The current market capitalization of Summit Therapeutics Inc is $2.41B. A total of 2.98 million shares were traded on the day, compared to an average of 1.22M shares.
In the most recent transaction, Dhingra Ankur bought 20,400 shares of SMMT for 2.17 per share on Dec 13. After the transaction, the Chief Financial Officer now owns 254,958 company shares. In a previous transaction on Dec 12, Zanganeh Mahkam bought 5,000 shares at 2.07 per share. SMMT shares that Chief Executive Officer owns now total 494,814.
Among the insiders who bought shares, Soni Manmeet Singh acquired of 2,976,190 shares on Oct 13 at a per-share price of $1.68. This resulted in the Chief Operating Officer holding 2,976,190 shares of SMMT after the transaction. In another insider transaction, Zanganeh Mahkam bought 15,973,743 shares at $1.05 per share on Mar 08. Company shares held by the Co-Chief Executive Officer now total 23,395,269.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, SMMT has a high of $5.10 and a low of $1.25.
As of this writing, SMMT has an earnings estimate of $0 per share for the current quarter. EPS was calculated based on a consensus of 0 estimates, with a high estimate of $0 per share and a lower estimate of $0.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. SMMT’s latest balance sheet shows that the firm has $71.79M in Cash & Short Term Investments as of fiscal 2021. There were $2.78M in debt and $25.62M in liabilities at the time. Its Book Value Per Share was $0.14, while its Total Shareholder’s Equity was $83.28M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SMMT is Buy with a score of 0.00.
